In an animal model with NAFLD, Wang (2018) found that lncRNA-NEAT1 knockdown may alleviate the NAFLD via regulating the mTOR/S6K1 signaling pathway. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.